Cargando…

Ceftolozane-tazobactam in nosocomial pneumonia

Ceftolozane is a potent antimicrobial against Pseudomonas aeruginosa, including carbapenem-resistant and multidrug-resistant strains, and is also active against Enterobacteriaceae. It MIC (minimal inhibitory concentration) and MPC (mutant preventive concentration) are close together, allowing to avo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Candel, Francisco Javier, del Castillo, Juan González, Jiménez, Agustín Julián, Matesanz, Mayra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedad Española de Quimioterapia 2022
Materias:	New Antimicrobial Alternatives in the Treatment of Pneumonia
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106209/ https://www.ncbi.nlm.nih.gov/pubmed/35488823 http://dx.doi.org/10.37201/req/s01.08.2022

Ejemplares similares

Erratum: Ceftolozane-tazobactam in nosocomial pneumonia
por: FJ, Candel, et al.
Publicado: (2022)

Ceftaroline in severe community-acquired pneumonia
por: Cilloniz, Catia, et al.
Publicado: (2022)

New evidence in severe pneumonia: meropenemvaborbactam
por: Guillot, María Forteza, et al.
Publicado: (2022)

New evidence in severe pneumonia: imipenem/ cilastatin/relebactam
por: Girón, Rosa Mª, et al.
Publicado: (2022)

Ceftobiprole medocaril
por: Méndez, Raúl, et al.
Publicado: (2022)

Ceftazidime-avibactam
por: Herrero, Francisco Sanz
Publicado: (2022)

Cefiderocol
por: Soriano, María Cruz, et al.
Publicado: (2022)

Ceftolozane-tazobactam: When, how and why using it?
por: López, Inmaculada, et al.
Publicado: (2021)

Safety and Efficacy of Ceftolozane/Tazobactam Versus Meropenem in Neonates and Children With Complicated Urinary Tract Infection, Including Pyelonephritis: A Phase 2, Randomized Clinical Trial
por: Roilides, Emmanuel, et al.
Publicado: (2023)

Safety and Efficacy of Ceftolozane/Tazobactam Plus Metronidazole Versus Meropenem From a Phase 2, Randomized Clinical Trial in Pediatric Participants With Complicated Intra-abdominal Infection
por: Jackson, Carl-Christian A., et al.
Publicado: (2023)

2200. Cost-effectiveness of Ceftolozane/Tazobactam for Treating Ventilated Nosocomial Bacterial Pneumonia
por: Naik, Jaesh, et al.
Publicado: (2019)

Value of syndromic panels in the management of severe community-acquired pneumonia
por: Burillo, Almudena, et al.
Publicado: (2022)

Ceftolozane/tazobactam pharmacokinetic/pharmacodynamic‐derived dose justification for phase 3 studies in patients with nosocomial pneumonia
por: Xiao, Alan J., et al.
Publicado: (2016)

Ultrasensitive and rapid identification of ESRI developer- and piperacillin/tazobactam-resistant Escherichia coli by the MALDIpiptaz test
por: Rodríguez Villodres, Angel, et al.
Publicado: (2022)

Population Pharmacokinetic Analysis for Plasma and Epithelial Lining Fluid Ceftolozane/Tazobactam Concentrations in Patients With Ventilated Nosocomial Pneumonia
por: Zhang, Zufei, et al.
Publicado: (2020)

Prevalence and correlates of treatment failure among Kenyan children hospitalised with severe community-acquired pneumonia: a prospective study of the clinical effectiveness of WHO pneumonia case management guidelines
por: Agweyu, Ambrose, et al.
Publicado: (2014)

Ceftazidime-avibactam
por: Matesanz, Mayra, et al.
Publicado: (2021)

Usefulness of thoracic ultrasound for diagnosis and follow-up of pneumonia
por: Pallarés, Javier Pérez, et al.
Publicado: (2022)

Failure of ceftolozane‐tazobactam salvage therapy in complicated pneumonia with lung abscess
por: Lewis, Paul O., et al.
Publicado: (2018)

Healthcare Resource Utilization of Ceftolozane/Tazobactam Versus Meropenem for Ventilated Nosocomial Pneumonia from the Randomized, Controlled, Double-Blind ASPECT-NP Trial
por: Lodise, Thomas, et al.
Publicado: (2020)

1319. Pharmacokinetics of Ceftolozane/Tazobactam in Patients with Burns
por: Hall, Ronald G, et al.
Publicado: (2020)

Bacteremic pneumococcal pneumonia: arrhythmogenic disease
por: Fernandez, Leyre Serrano, et al.
Publicado: (2022)

Ceftolozane-Tazobactam Combination Therapy Compared to Ceftolozane-Tazobactam Monotherapy for the Treatment of Severe Infections: A Systematic Review and Meta-Analysis
por: Fiore, Marco, et al.
Publicado: (2021)

Computed tomography in children with community-acquired pneumonia
por: Andronikou, Savvas, et al.
Publicado: (2017)

Lung ultrasound for the diagnosis of community-acquired pneumonia in children
por: Stadler, Jacob A. M., et al.
Publicado: (2017)

2227. Outcomes in Patients with Renal Impairment from a Phase 3 Clinical Trial for Ceftolozane–Tazobactam (C/T) Treatment of Nosocomial Pneumonia (ASPECT-NP)
por: Huntington, Jennifer A, et al.
Publicado: (2019)

Community-acquired pneumonia in children — a changing spectrum of disease
por: le Roux, David M., et al.
Publicado: (2017)

Usefulness of monocyte distribution width (MDW) as a sepsis biomarker
por: Martínez, Sara Laínez, et al.
Publicado: (2022)

Guidelines for the use of chest radiographs in community-acquired pneumonia in children and adolescents
por: Andronikou, Savvas, et al.
Publicado: (2017)

Recurrent ventilator-associated pneumonia caused by “difficult to treat” resistance Pseudomonas aeruginosa
por: Rodríguez-Aguirregabiria, Montserrat, et al.
Publicado: (2022)

Efflux Pump AcrAB Confers Decreased Susceptibility to Piperacillin–Tazobactam and Ceftolozane–Tazobactam in Tigecycline-Non-Susceptible Klebsiella pneumoniae
por: Li, Junjie, et al.
Publicado: (2020)

Pulmonary Nocardiosis. A case report
por: González-Jiménez, Paula, et al.
Publicado: (2022)

Mechanical ventilation associated pneumonia during ECMO therapy. A challenge for the Intensive Care physician
por: Costa, José Ricardo Gimeno
Publicado: (2022)

Piperacillin/tazobactam administered by continuous or intermittent infusion for the treatment of nosocomial pneumonia
por: Lorente, L, et al.
Publicado: (2009)

Patient Detection of a Drug Dispensing Error by Use of Physician-Provided Drug Samples
por: Ashley, Elizabeth S Dodds, et al.
Publicado: (2002)

Science or Fiction: Use of Nesiritide as a First-Line Agent?
por: Noviasky, John A, et al.
Publicado: (2003)

Assessing the risk of stroke from neck manipulation: a systematic review
por: Haynes, M J, et al.
Publicado: (2012)

Assessment of food habits in children aged 6–12 years and the risk of caries
por: Doichinova, Liliya, et al.
Publicado: (2015)

Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies
por: Law, Arjun Datt, et al.
Publicado: (2018)

Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosa
por: Barnes, Melissa D., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pbpimab2hbv1hna7llj5radnjo